AI Mistakes Pharmacists Should Avoid in Australia (2026)

AI tools are becoming more common in Australian pharmacy practice, and most pharmacists are finding genuine value in them. But as adoption grows, so do the mistakes — some of which carry serious professional, regulatory, and patient safety consequences. Understanding the most common AI mistakes pharmacists make is the first step to avoiding them.

This article covers the mistakes that matter most for Australian pharmacists using AI in 2026, and what to do instead.

Treating AI Interaction Alerts as Definitive

AI-powered drug interaction checking tools are valuable safety tools — but they are not infallible, and their alerts are not all equally clinically significant. The most common mistake pharmacists make with AI interaction checkers is treating every alert as equally important, or conversely, dismissing alerts without adequate clinical review.

AI interaction checkers can generate alerts for interactions that are theoretical, minor in clinical practice, or well-managed with appropriate monitoring. They can also miss interactions that are not well-represented in their training data. The pharmacist's role is to review each alert, assess its clinical significance in the context of the individual patient's circumstances, and determine the appropriate course of action.

Treating AI alerts as definitive — either by acting on every alert without clinical judgement, or by dismissing alerts because the AI "usually" generates too many — is a professional error. The pharmacist remains responsible for all dispensing decisions.

Alert Fatigue Leading to Missed Safety Issues

Alert fatigue is a well-documented problem in healthcare settings where AI clinical decision support tools generate large numbers of alerts. When pharmacists are overwhelmed by alerts — many of which are minor or not clinically relevant — they may begin to dismiss alerts without adequate review, increasing the risk of missing a genuinely significant safety issue.

If you are experiencing alert fatigue with your dispensing software's clinical decision support features, raise it with your pharmacy management or software provider. Many systems allow alert thresholds to be configured to reduce the volume of low-significance alerts. The goal is a system that generates clinically actionable alerts — not one that generates so many alerts that they become background noise.

Entering Patient Data into Public AI Tools

Pharmacists who use public AI tools like ChatGPT for work-related tasks sometimes include patient names, dates of birth, Medicare numbers, medication histories, or other identifying information in their prompts. This is a breach of the Privacy Act 1988 and the Australian Privacy Principles, and potentially a breach of the Pharmacy Board of Australia's standards for practice.

The fix is straightforward: never enter any patient-identifying information into a public AI tool. Use AI tools only for tasks that don't involve patient data — template creation, CPD preparation, general clinical education — or use only tools that have been approved for use with patient data and that comply with Australian privacy legislation.

Over-Relying on AI for Clinical Decisions

AI tools can provide clinical information, generate interaction alerts, and support medication review — but they cannot replace the pharmacist's professional knowledge, clinical judgement, and understanding of the individual patient's circumstances.

The mistake is treating AI outputs as clinical decisions. A pharmacist who dispenses a medication because the AI didn't flag an interaction, without applying their own clinical review, has made a professional error. A pharmacist who follows an AI-generated medication review recommendation without critically evaluating it has also made a professional error.

AI is decision support, not decision making. Use it to inform your thinking, not to replace it.

Failing to Keep AI Knowledge Current

AI tools in pharmacy practice are evolving rapidly. New tools are being developed, existing tools are being updated, and the evidence base for AI in pharmacy is growing. Pharmacists who adopted AI tools early and haven't revisited their use may be using outdated tools or missing opportunities to use better ones.

Make AI literacy part of your ongoing professional development. Stay current with developments in pharmacy AI through professional associations, CPD activities, and peer networks. Review the AI tools you use periodically to ensure they are still appropriate and that you are using them effectively.

Neglecting to Disclose AI Use When Required

Some clinical contexts require disclosure when AI tools have been used — for example, when AI has contributed to a medication review report or a clinical recommendation. Failing to disclose AI use when it is required, or when a patient or colleague asks, is a transparency issue.

Be familiar with your obligations under the Pharmacy Board of Australia's standards regarding transparency and professional conduct. When AI tools contribute to clinical decisions or documentation, be prepared to explain how they were used and what role they played.

Getting the Balance Right

The pharmacists who use AI most effectively are those who approach it with clear professional boundaries — they know what AI can and can't do, they use it only for appropriate tasks, they review its outputs critically, and they maintain their professional accountability at all times. AI is a tool that can make pharmacy practice safer and more efficient — but only when it is used thoughtfully and within the professional and ethical framework that governs pharmacy practice in Australia.